Blackstone Life Sciences

	Start	2018-10-04 renamed
	Group	Blackstone (Group)
	Predecessor	Clarus Ventures LLC
	Industry	venture capital
	Industry 2	LIFE SCIENCES
	Person	Galakatos, Nicholas (Clarus Ventures 200906 Managing Director + co-founder)
	Person 2	Steinmetz, Michael (Clarus Ventures 2005– Managing Director before MPM Asset General Partner before Roche)

	Region	Cambridge, MA
	Country	United States (USA)
	City	n. a. Cambridge, MA
		Address record changed: 2018-12-19

Basic data	Employees	n. a.


		Record changed: 2021-02-21

Picture [iito] Plain Stupid Simple 650x80px

More documents for Blackstone (Group)

[1] Ferring Pharmaceuticals S.A.. (11/25/19). "Press Release: Ferring and Blackstone Life Sciences Invest over $570 Million USD in Novel Gene Therapy for Bladder Cancer Patients". Saint-Prex & Cambridge, MA....
[2] Blackstone. (10/4/18). "Press Release: Blackstone Announces Agreement to Acquire Clarus, a Leading Life Sciences Investment Firm". New York, NY....
[3] Annexon Biosciences. (3/9/17). "Press Release: Annexon Biosciences Appoints Bill Young as Chairman and Adds Tom Wiggans to Board of Directors". South San Francisco, CA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]